Early predictors of improved long-term outcomes in first-line antiangiogenics plus chemotherapy (anti-ANG/CT) in metastatic colorectal cancer (mCRC): Analysis of individual patient (pt) data from the ARCAD database.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Everardo D. Saad, Elisabeth Coart, Dirkje Willemien Sommeijer, Qian Shi, John Raymond Zalcberg, Tomasz Burzykowski, Jeffrey P. Meyers, Paulo Marcelo Hoff, J. Randolph Hecht, Herbert Hurwitz, Jolien Tol, Niall C. Tebbutt, Charles S. Fuchs, Eduardo Diaz-Rubio, John Souglakos, Alfredo Falcone, Fairooz F. Kabbinavar, Daniel J. Sargent, Aimery De Gramont, Marc E. Buyse, for the ARCAD Group
Institutions: International Drug Development Institute (Belgium), Amsterdam UMC Location University of Amsterdam, Mayo Clinic, Peter MacCallum Cancer Centre, Instituto do Câncer do Estado de São Paulo, University of California, Los Angeles, Duke Medical Center, Radboud University Nijmegen, Radboud University Medical Center, Austin Health, Dana-Farber Cancer Institute, Hospital Clínico San Carlos, University Hospital of Heraklion, Azienda Ospedaliera Universitaria Pisana, Hôpital Saint-Antoine
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2907025785